Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORACEA in Geographic Atrophy
NCT01782989Phase 3Completed
- Start
- Feb 2013
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxycycline in geographic atrophy (GA). Started Feb 2013; status: completed.
02
Drugs
doxycycline
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01782989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782989.